Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Drospirenone 4mg tablets
0703021R0AAAAAA
|
Drospirenone | Drospirenone | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,075 |
|
Diamorphine 5mg powder for solution for injection ampoules
0407020K0AAAAAA
|
Diamorphine hydrochloride (Systemic) | Diamorphine hydrochloride (Systemic) | Central Nervous System | 2,074 |
|
LINC all silicone open tipped suprapubic cath + integral balloon & water filled syrg stnd 16Ch-24Ch
21020001433
|
LINC all silicone open tipped suprapubic cath + integral balloon & water filled syrg stnd 16Ch-24Ch | Catheters | Appliances | 2,074 |
|
Amlodipine 5mg / Valsartan 160mg tablets
0206020Z0AAABAB
|
Valsartan/amlodipine | Valsartan/amlodipine | Cardiovascular System | 2,073 |
|
Eucerin Intensive 10% lotion
1302010U0BGACAM
|
Eucerin | Urea | Skin | 2,073 |
|
Cymbalta 60mg gastro-resistant capsules
0403040Y0BBABAB
|
Cymbalta (Antidepressant) | Duloxetine hydrochloride | Central Nervous System | 2,072 |
|
Midazolam 5mg/1ml oromucosal soln pf oral syringes SF
0408020W0AAABAB
|
Midazolam hydrochloride (Buccal) | Midazolam hydrochloride | Central Nervous System | 2,072 |
|
Daktarin 20mg/g oromucosal gel
1203020H0BBAAAA
|
Daktarin (Mouthwash) | Miconazole | Ear, Nose and Oropharynx | 2,071 |
|
Quetiapine 400mg tablets
0402010ABAABIBI
|
Quetiapine | Quetiapine | Central Nervous System | 2,071 |
|
Slozem 240mg capsules
0206020C0BIACAW
|
Slozem | Diltiazem hydrochloride | Cardiovascular System | 2,070 |
|
Glutafin gluten free white loaf sliced
0913271A0BDAIAN
|
Glutafin specialist food replacer bread | Specialist food replacer bread (0913271) | Nutrition and Blood | 2,068 |
|
Oxycodone 5mg tablets
0407020ADAAATAT
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 2,068 |
|
Foodlink Complete powder (5 flavours)
0913011C0BFAFAC
|
Foodlink powder 1.6 kcal/ml milkshake | Powder 1.6 kcal/ml milkshake (0913011) | Nutrition and Blood | 2,066 |
|
Nicotine 7mg/24hours transdermal patches
0410020B0AAAPAP
|
Nicotine | Nicotine | Central Nervous System | 2,066 |
|
Opiodur 50micrograms/hour transdermal patches (Zentiva)
0407020A0BRAMAF
|
Opiodur | Fentanyl | Central Nervous System | 2,065 |
|
Azilect 1mg tablets
0409010Y0BBAAAA
|
Azilect | Rasagiline mesilate | Central Nervous System | 2,063 |
|
Prontosan Wound Gel gel dressing
20030500045
|
Prontosan Wound Gel gel dressing | Wound Management & Other Dressings | Dressings | 2,063 |
|
Disopyramide 100mg capsules
0203020F0AAABAB
|
Disopyramide | Disopyramide | Cardiovascular System | 2,061 |
|
Oseltamivir 75mg capsules
0503040B0AAAAAA
|
Oseltamivir phosphate | Oseltamivir phosphate | Infections | 2,060 |
|
Lyrica 50mg capsules
0408010AEBBABAB
|
Lyrica | Pregabalin | Central Nervous System | 2,056 |
|
Fresubin 2kcal Fibre drink (6 flavours)
0913011U0BBAAAA
|
Fresubin RtS 2 kcal/ml m/sk high protein, high energy+fibre | RtS 2 kcal/ml m/sk high protein, high energy+fibre (0913011) | Nutrition and Blood | 2,053 |
|
Actreen Hi-Lite catheter male Tiemann tip 8Ch-16Ch
21020001227
|
Actreen Hi-Lite catheter male Tiemann tip 8Ch-16Ch | Catheters | Appliances | 2,051 |
|
Qufora IrriSedo Mini System 15 irrigation set
21280000110
|
Qufora IrriSedo Mini System 15 irrigation set | Anal Irrigation System | Appliances | 2,050 |
|
Toviaz 4mg modified-release tablets
0704020ADBBAAAA
|
Toviaz | Fesoterodine fumarate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,047 |
|
Diphtheria/Tetanus/IPV vacc (ads) inj 0.5ml pfs
1404000F0AAAWAW
|
Diphtheria | Diphtheria | Immunological Products and Vaccines | 2,045 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.